Edition:
India

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

27.63USD
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
$27.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
186,211
52-wk High
$28.06
52-wk Low
$14.24

Select another date:

Tue, Feb 27 2018

BRIEF-Diplomat Pharmacy Posts Q4 Adj. Earnings Per Share $0.18

* DIPLOMAT ANNOUNCES 4TH QUARTER AND 2017 YEAR END FINANCIAL RESULTS; PROVIDES 2018 GUIDANCE

BRIEF-Diplomat Pharmacy Says Dispensing Advanced Kidney Treatment, CABOMETYX

* DIPLOMAT PHARMACY INC - ‍IS DISPENSING EXELIXIS' LIMITED-DISTRIBUTION TREATMENT CABOMETYX NOW WITH AN EXPANDED INDICATION​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook

* DIPLOMAT PHARMACY INC - ‍JEFF PARK, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY​

BRIEF-Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook

* - EXPECTS 2017 REVENUE TO BE NEAR MIDDLE OF PREVIOUSLY PROVIDED RANGE

Select another date: